Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia

Wataru Munakata, Naohiro Sekiguchi, MD PhD, Rai Shinya, MD,PhD, Kenshi Suzuki, MD PhD, Hiroshi Handa, MD PhD, Hirohiko Shibayama, MD PhD, Tomoyuki Endo, MD PhD, Yasuhito Terui, MD PhD, Noriko Iwaki, MD PhD, Noriko Fukuhara, MD PhD, Hiro Tatetsu, MD PhD, Shinsuke Iida, MD PhD, Takayuki Ishikawa, MD PhD, Ryota Shiibashi, Koji Izutsu, MD PhD

Blood (2019) 134 (Supplement_1): 345.

https://doi.org/10.1182/blood-2019-124614

Published: 2019

Journal Articles

Positivity Rate of Systematic Bone Marrow Smear Above 60-Year-Old Patients with Newly Diagnosed Immune Thrombocytopenia to Screen for Associated Hematological Malignancy. Results from the French Prospective Multicenter Carmen Registry

Blood (2019) 134 (Supplement_1): 1083.

https://doi.org/10.1182/blood-2019-122821

Published: 2019

Journal Articles

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Mahsen AlSaleh, MD, Tarek Owaidah, MD, Hazzaa Alzahrani, MD, Tahani Bin Ali, MD, Huda ElFaraidi, MD, Mahmoud Abu Riash, RN, Zikra Alkhayal, MD, AbdulKareem Al Momen, MD, Viqaruddin Mohammed, MSc, CCRP, Azzah AlZahrani, MD

Blood (2017) 130 (Supplement 1): 5587.

https://doi.org/10.1182/blood.V130.Suppl_1.5587.5587

Published: 2017

Journal Articles

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Jessica Garcia, MD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Paula D. James, MD, Pippa Simpson, PhD, Liyun Zhang, MS, Thomas C. Abshire, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 1075.

https://doi.org/10.1182/blood.V130.Suppl_1.1075.1075

Published: 2017

Journal Articles

Management of Newly Diagnosed Paediatric ITP in UK

Daniella Cudner, John D. Grainger, MD MRCP, FRPATH

Blood (2017) 130 (Supplement 1): 3627.

https://doi.org/10.1182/blood.V130.Suppl_1.3627.3627

Published: 2017

Journal Articles

HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors

Guy Young, Robert F. Sidonio, Ri Liesner, Johannes Oldenburg, Tiffany Chang, Marianne Uguen, Christophe Dhalluin, Christophe Schmitt, Gallia G. Levy, Midori Shima, MDPhD, Johnny Mahlangu

Blood (2017) 130 (Supplement 1): 85.

https://doi.org/10.1182/blood.V130.Suppl_1.85.85

Published: 2017

Journal Articles

Anticoagulation Therapy Considerations in Left Ventricular Assist Devices in the Setting of Factor VII Deficiency

Anuhya Kommalapati, MD, Sri Harsha Tella, MD, Allan-Louie Cruz, MD

Blood (2017) 130 (Supplement 1): 4898.

https://doi.org/10.1182/blood.V130.Suppl_1.4898.4898

Published: 2017

Journal Articles

Response to First Line Treatment in Childhood ITP

John D. Grainger, MD BMBch, MRCP, FRCPATH, Paula H. B Bolton-Maggs, BMBCh, DM, FRCP, FRCPath, Pearce Elizabeth

Blood (2016) 128 (22): 1372.

https://doi.org/10.1182/blood.V128.22.1372.1372

Published: 2016

Journal Articles

Comparison of Bleeding Tools in a Cohort of Pediatric Patients with ITP: Data from the Pediatric ITP Consortium of North America ICON1 Study

Blood (2016) 128 (22): 4752.

https://doi.org/10.1182/blood.V128.22.4752.4752

Published: 2016

Journal Articles

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

John Grainger, James B. Bussel, MD, Nichola Cooper, Michael Tarantino, Victor Blanchette, Jenny Despotovic, Alexey Maschan, MD PhD, Nancy Carpenter, Melissa Eisen, Bhakti Mehta

Blood (2016) 128 (22): 869.

https://doi.org/10.1182/blood.V128.22.869.869

Published: 2016

Journal Articles

The Results of the Russian Registry of Primary Immune Thrombocytopenia (ITP) in Adults

Blood (2015) 126 (23): 4642.

https://doi.org/10.1182/blood.V126.23.4642.4642

Published: 2015

Journal Articles

Results of the Russian Registry of Primary Immune Thrombocytopenia in Pediatric Patients

Anastasia Shamardina, MD, Inna Markova, MD, Tatyana Sycheva, MD, Elena Volodicheva, MD, Alexander Rumyantsev, Prof, Boris V Afanasyev, Professor, Michael A Maschan, MD PhD, Alexey Maschan, Prof

Blood (2015) 126 (23): 4643.

https://doi.org/10.1182/blood.V126.23.4643.4643

Published: 2015

Journal Articles

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

Michael D Tarantino, MD, James B. Bussel, MD, Victor S. Blanchette, MD FRCP, Jenny M. Despotovic, DO, MS, Carolyn Bennett, Ashok Raj, MD, Bronwyn Williams, Donald Beam, Jaime Morales, Melissa J. Rose, DO, Kun Nie, Melissa Eisen, MD

Blood (2015) 126 (23): 3467.

https://doi.org/10.1182/blood.V126.23.3467.3467

Published: 2015

Journal Articles

Can Immature Platelet Fraction (IPF) be Used to Assess Bleeding Risk in Pediatric Immune Thrombocytopenia (ITP) and to Differentiate ITP from Bone Marrow Failure/Aplastic Anemia? A Retrospective Analysis

Karen Lee Bride, MDPhD, Derick Lim, Michele Paessler, DO, Michele P Lambert, MD

Blood (2015) 126 (23): 3474.

https://doi.org/10.1182/blood.V126.23.3474.3474

Published: 2015

Journal Articles

Safety and Efficacy of Long-Term Open-Label Dosing of Romiplostim in Thrombocytopenic Pediatric Patients (Pts) with Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Michael D. Tarantino, Amy Geddis, Michael F. Guerrera, Alan K. Ikeda, Kun Nie, Janet Franklin, Melissa Eisen

Blood (2014) 124 (21): 4184.

https://doi.org/10.1182/blood.V124.21.4184.4184

Published: 2014

Journal Articles

A Phase 1 Study of Azacitidine (AZA) in Combination with Fludarabine and Cytarabine in Relapse/Refractory Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Weili Sun, MDPhD, Paul S Gaynon, MD, Richard Sposto, PhD, Henrique Bittencourt, MD, Andrew E. Place, MDPhD, Yoav H Messinger, MD, Chris Fraser, MD, Luciano Dalla-Pozza, MD, Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Xiaojing Yang, PhD, Gangning Liang, PhD, Peter A. Jones, PhD DSc, Alan S. Wayne, MD, Todd Cooper, DO

Blood (2014) 124 (21): 3764.

https://doi.org/10.1182/blood.V124.21.3764.3764

Published: 2014

Journal Articles

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

Pamela A Christopherson, Veronica H Flood, MD, Kenneth D. Friedman, MD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Robert R Montgomery, MD, Thomas C. Abshire, MD, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1510.

https://doi.org/10.1182/blood.V124.21.1510.1510

Published: 2014

Journal Articles

The Use Of Simple Patient Blood Management Strategies As An Alternative To Platelet and Red Cell Transfusion In Autologous Stem Cell Transplant

Patricia A. Locantore-Ford, MD, Shakira Jeanene Grant, MBBS, Gina Keck, RN

Blood (2013) 122 (21): 2140.

https://doi.org/10.1182/blood.V122.21.2140.2140

Published: 2013

Journal Articles

Discordance in Provider Practice Patterns and Hemophilia A Carrier Health Care Preferences

Allison Paroskie, MD, Olatunde Ooso, BS, Benjamin Almassi, Michael R. DeBaun, MD, MPH, Robert F Sidonio, Jr., MD, MSc

Blood (2012) 120 (21): 3385.

https://doi.org/10.1182/blood.V120.21.3385.3385

Published: 2012

Journal Articles

Safety and Efficacy of the mTOR Inhibitor Everolimus as Early Interventional Replacement for Calcineurin Inhibitors In Graft-Versus-Host Disease (GvHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Herbert G. Sayer, MD, Anne Klink, Thomas Schenk, MD, Anne Treschl, MD, Kristina Schilling, MD, Andreas Hochhaus, MD

Blood (2010) 116 (21): 2325.

https://doi.org/10.1182/blood.V116.21.2325.2325

Published: 2010

NARROW

Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia

Positivity Rate of Systematic Bone Marrow Smear Above 60-Year-Old Patients with Newly Diagnosed Immune Thrombocytopenia to Screen for Associated Hematological Malignancy. Results from the French Prospective Multicenter Carmen Registry

Positive Impact of Social Media on Disease Awareness and Management in Patients with Inherited Bleeding Disorders: Saudi Experience from a Tertiary Care Hospital

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Management of Newly Diagnosed Paediatric ITP in UK

HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors

Anticoagulation Therapy Considerations in Left Ventricular Assist Devices in the Setting of Factor VII Deficiency

Response to First Line Treatment in Childhood ITP

Comparison of Bleeding Tools in a Cohort of Pediatric Patients with ITP: Data from the Pediatric ITP Consortium of North America ICON1 Study

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

The Results of the Russian Registry of Primary Immune Thrombocytopenia (ITP) in Adults

Results of the Russian Registry of Primary Immune Thrombocytopenia in Pediatric Patients

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

Can Immature Platelet Fraction (IPF) be Used to Assess Bleeding Risk in Pediatric Immune Thrombocytopenia (ITP) and to Differentiate ITP from Bone Marrow Failure/Aplastic Anemia? A Retrospective Analysis

Safety and Efficacy of Long-Term Open-Label Dosing of Romiplostim in Thrombocytopenic Pediatric Patients (Pts) with Immune Thrombocytopenia (ITP)

A Phase 1 Study of Azacitidine (AZA) in Combination with Fludarabine and Cytarabine in Relapse/Refractory Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

The Use Of Simple Patient Blood Management Strategies As An Alternative To Platelet and Red Cell Transfusion In Autologous Stem Cell Transplant

Discordance in Provider Practice Patterns and Hemophilia A Carrier Health Care Preferences

Safety and Efficacy of the mTOR Inhibitor Everolimus as Early Interventional Replacement for Calcineurin Inhibitors In Graft-Versus-Host Disease (GvHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only